Loading clinical trials...
Loading clinical trials...
Prospective Trial for Comparison of a TauroLock™ Based Regimen to 4% Citrate as Lock Solution in Tunneled Haemodialysis Catheters for the Prevention of Bacteraemia and Dysfunction
Conditions
Interventions
4% citrate lock solution regimen
TauroLock lock solution regimen
Locations
1
Austria
Department of Medicine III, Division of Nephrology and Dialysis, Medical University of Vienna
Vienna, Vienna, Austria
Start Date
January 1, 2012
Primary Completion Date
August 1, 2016
Last Updated
December 5, 2016
NCT04634916
NCT06933472
NCT07224763
NCT07033260
NCT05738525
NCT06373575
Lead Sponsor
Medical University of Vienna
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions